Source: West, S et al Weight regain after cessation of medication for weight management: systematic review and meta-analysis, BMJ January, 2026 Newer incretin mimetics are the GLP-1 medications semaglutide and tirzepatide
Online patient communities work a lot like a neighbourhood grapevine
We assumed that patients had ongoing semaglutide use between consecutive prescriptions (irrespective of the duration between prescriptions) and that semaglutide use was ongoing for 3 months after the last available prescription
Paul Grayson, a patient taking Ozempic for obesity, reported to NPR last year: Before Ozempic, I could consume a whole bottle of wine in an evening without trying real hard But with Ozempic, even one beer didnt feel good to me somehow. Many patients simply dont crave substances like they used to
Research Procurement Checklist for BPC-157+TB-500 Blend Verify that BPC-157+TB-500 Blend is labeled for research use only
Wegovy is approved for chronic weight management in eligible patients, while Ozempic is approved for type 2 diabetes